Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study von Sgroi, Dennis C, Treuner, Kai, Zhang, Yi, Piper, Tammy, Salunga, Ranelle, Ahmed, Ikhlaaq, Doos, Lucy, Thornber, Sarah, Taylor, Karen J, Brachtel, Elena, Pirrie, Sarah, Schnabel, Catherine A, Rea, Daniel, Bartlett, John M S

Volltext

Impaired insulin secretion in a mouse model of ataxia telangiectasia von Miles, Philip D, Treuner, Kai, Latronica, Marc, Olefsky, Jerrold M, Barlow, Carrolee

Volltext

Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice von TREUNER, Kai, HELTON, Rob, BARLOW, Carrolee

Volltext

PP01.30 Integration of molecular cancer classification and NGS to identify patients with cancer of unknown primary (CUP) and other unclear diagnoses eligible for KRAS inhibitors von Fuentes Bayne, Harry E., Ma, Li, Wong, Jenna, Treuner, Kai, Halfdanarson, Thorvardur R.

Volltext

Abstract P6-04-17: Role of HOXB13 in modulating estrogen signaling in breast cancer cells von Treuner, Kai, Hayes, Michael, Benner, Christopher, Schnabel, Catherine, Heinz, Sven

Volltext

Integration of molecular cancer classification and NGS to identify patients with metastatic cancer eligible for BRAF inhibitors von Fuentes Bayne, Harry E., Ma, Li, Wong, Jenna, Treuner, Kai, Halfdanarson, Thorvardur Ragnar

Volltext

Integration of molecular cancer classification and NGS to identify metastatic patients eligible for IDH inhibitors von Kasi, Pashtoon Murtaza, Ma, Li, Treuner, Kai, Wong, Jenna, Schnabel, Catherine A.

Volltext

Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy von Noordhoek, Iris, Treuner, Kai, Putter, Hein, Zhang, Yi, Wong, Jenna, Kranenbarg, Elma Meershoek-Klein, Duijm-de Carpentier, Marjolijn, van de Velde, Cornelis J. H., Schnabel, Catherine A., Liefers, Gerrit-Jan

Volltext

Analysis of the MOSAIC correlative cancer database integrating molecular cancer classification and tumor profiling to identify targeted treatment options for metastatic cancer von Ma, Li, Treuner, Kai, Wong, Jenna, Spigel, David R., Schnabel, Catherine A., Greco, F Anthony

Volltext

Integration of molecular cancer classification and next-generation sequencing to identify metastatic patients eligible for PARP inhibitors von Hart, Lowell L., Treuner, Kai, Ma, Li, Wong, Jenna, Schnabel, Catherine A., Reeves, James Andrew

Volltext

Abstract PS17-32: Characterization of HOXB13-induced estrogen receptor reprogramming in breast cancer cells von Treuner, Kai, Schenone, Dominic, Benner, Christopher, Schnabel, Catherine A, Heinz, Sven

Volltext

DNA instability in the brain: survival of the 'fittest' von Barlow, Carrolee, Treuner, Kai

Volltext

The Breast Cancer Index Registry Study: Initial analysis of the first 1,000 patients von O'Shaughnessy, Joyce, Encarnacion, Carlos A., O'Neal, Brandon, Wong, Jenna, Siuliukina, Natalia, Sanft, Tara B., Jankowitz, Rachel Catherine, Pegram, Mark D., Treuner, Kai, Fox, Jenny R.

Volltext

Abstract OT1-10-01: The Breast Cancer Index registry study: A prospective multi-center observational study to evaluate patient outcome, clinical impact, and medication adherence in... von O'Shaughnessy, Joyce A, Fox, Jenny R, Encarnación, Carlos A, O'Neal, Brandon, Treuner, Kai, Sanft, Tara, Jankowitz, Rachel C, Pegram, Mark D, Schnabel, Catherine A, Diab, Sami G

Volltext

Abstract PD15-04: Breast Cancer Index and assessment of the Net Treatment Benefit (NTB) of extended endocrine therapy in HR+ breast cancer von Buyse, Marc, Wong, Jenna, Salvaggio, Samuel, Chiem, Jean-Christophe, Zhang, Yi, Treuner, Kai, Kranenbarg, Elma Meershoek-Klein, De Backer, Mickaël, Liefers, Gerrit-Jan, Schnabel, Catherine A

Volltext

Abstract P3-11-10: Estrogen receptor reprogramming by HOXB13 and GATA3 in ER-positive breast cancer cells von Treuner, Kai, De Arruda Saldanha, Camila, Heinz, Sven

Volltext

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study von Bartlett, John M S, Sgroi, Dennis C, Treuner, Kai, Zhang, Yi, Piper, Tammy, Salunga, Ranelle C, Ahmed, Ikhlaaq, Doos, Lucy, Thornber, Sarah, Taylor, Karen J, Brachtel, Elena F, Pirrie, Sarah J, Schnabel, Catherine A, Rea, Daniel W

Volltext

Breast Cancer Index and prediction of benefit from extended endocrine therapy based on treatment compliance: An IDEAL study von Liefers, Gerrit-Jan, Noordhoek, Iris, Treuner, Kai, Putter, Hein, Wong, Jenna, Zhang, Yi, Meershoek – Klein Kranenbarg, Elma, Van De Velde, Cornelis J.H., Schnabel, Catherine A.

Volltext

Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study von Liefers, Gerrit-Jan, Noordhoek, Iris, Putter, Hein, Wong, Jenna, Siuliukina, Natalia, Zhang, Yi, Meershoek – Klein Kranenbarg, Elma, Duijm-de Carpentier, Marjolijn, Van De Velde, Cornelis J.H., Schnabel, Catherine A., Treuner, Kai

Volltext

Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma von Nunes, Raquel, Sella, Tal, Treuner, Kai, Atkinson, Jennifer M., Wong, Jenna, Zhang, Yi, Exman, Pedro, Dabbs, David, Richardson, Andrea L., Schnabel, Catherine A., Sgroi, Dennis C., Oesterreich, Steffi, Cimino-Mathews, Ashley, Metzger, Otto

Volltext